Literature DB >> 20120351

[Two cases of Guillain-Barré syndrome in late pregnancy].

Toshihiko Araki1, Hiroaki Nakata, Susumu Kusunoki.   

Abstract

We describe two patients who developed progressive ascending paralysis associated with Guillain-Barré syndrome (GBS) during late pregnancy. A 25-year-old woman in the 30th week of gestation (GW) developed diarrhea followed by GBS and weakness of the bilateral facial muscles. Serum IgM antibody titers against cytomegalovirus (CMV) were high. Respiratory insufficiency developed at GW 31 requiring cesarean section and artificial ventilation. The facial palsy and limb paralysis persisted thereafter. Serum anti-GM2 IgM and anti-GalNAc-GD1a IgM antibodies were positive so immunoadsorption therapy (IAT) was applied. These antibody titers decreased with clinical improvement after IAT. The baby was healthy and did not have CMV. The other patient was a 24-year-old woman at GW 28 in whom GBS developed after a common cold. Right facial muscles were also weak and serum anti-GM2 IgM antibody was positive. Cesarean section was performed because of uterine bleeding. The clinical findings improved thereafter and the baby was healthy. The findings show that the course of GBS that develops after CMV infection can be severe and accompanied by respiratory insufficiency.

Entities:  

Mesh:

Year:  2010        PMID: 20120351     DOI: 10.5692/clinicalneurol.50.24

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  Guillain-Barré syndrome in two patients with respiratory failure and a review of the Japanese literature.

Authors:  Erei Sohara; Takeshi Saraya; Kojiro Honda; Atsuko Yamada; Toshiya Inui; Yukari Ogawa; Mitsuru Sada; Naoki Tsujimoto; Masuo Nakamura; Akiko Tsuchiya; Masaki Saito; Chizuko Oishi; Atsuro Chiba; Hajime Takizawa; Hajime Goto
Journal:  J Thorac Dis       Date:  2012-12       Impact factor: 2.895

Review 2.  Neuromuscular disorders in pregnancy.

Authors:  Louis H Weimer
Journal:  Handb Clin Neurol       Date:  2020
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.